Skip to main content
Morie Gertz, MD, Hematology, Rochester, MN

Morie A Gertz MD MACP

Hematologic Oncology


Professor of Hematology & Oncology, Mayo Medical School

Join to View Full Profile
  • 200 1st Street SWRochester, MN 55905

Dr. Gertz is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

Education & Training

  • Mayo Clinic College of Medicine and Science (Rochester)
    Mayo Clinic College of Medicine and Science (Rochester)Fellowship, Hematology and Medical Oncology, 1979 - 1983
  • Rush University Medical Center
    Rush University Medical CenterResidency, Internal Medicine, 1976 - 1979
  • Ascension Illinois/Saint Joseph (Chicago)
    Ascension Illinois/Saint Joseph (Chicago)Residency, Internal Medicine, 1976 - 1976
  • Loyola University Chicago Stritch School of Medicine
    Loyola University Chicago Stritch School of MedicineClass of 1975
  • Northwestern University
    Northwestern UniversityB.A., Arts and Sciences, With Highest Distinction, 1972
  • Northwestern University
    Northwestern UniversityBA, Arts and Sciences, with Highest Distinction, 1972

Certifications & Licensure

  • AZ State Medical License
    AZ State Medical License 1989 - 2026
  • MN State Medical License
    MN State Medical License 1979 - 2025
  • IL State Medical License
    IL State Medical License 1977 - 1987
  • Internal Medicine
    American Board of Internal Medicine Internal Medicine
  • Hematology
    American Board of Internal Medicine Hematology
  • Medical Oncology
    American Board of Internal Medicine Medical Oncology

Awards, Honors, & Recognition

  • Jan Waldenstrom Medal for Medical and Scientific Achievements in Waldenstrom's Macroglobulinemia in Parliament Mayo Clinic, 2014
  • America's Top Doctors Castle Connolly, 2004-2014
  • America's Top Doctors for Cancer Castle Connolly, 2005-2013
  • Join now to see all

Clinical Trials

Publications & Presentations

PubMed

Journal Articles

  • Systemic Amyloidosis Recognition, Prognosis, and Therapy  
    Morie A Gertz, Angela Dispenzieri, JAMA
  • Impact of Prior Diagnosis of Monoclonal Gammopathy on Outcomes in Newly Diagnosed Multiple Myeloma  
    S Vincent Rajkumar, Yi L Hwa, Wilson I Gonsalves, Francis K Buadi, Angela Dispenzieri, Prashant Kapoor, Miriam A Hobbs, Martha Q Lacy, John A Lust, Robert A Kyle, Mori..., Nature
  • Safety and Efficacy of Propylene Glycol-Free Melphalan as Conditioning in Patients with AL Amyloidosis Undergoing Stem Cell Transplantation  
    Nelson Leung, Prashant Kapoor, Taxiarchis V Kourelis, Eli Muchtar, Angela Dispenzieri, M Hasib Sidiqi, Martha Q Lacy, Wilson I Gonsalves, Shaji K Kumar, Mohammed A Alj..., Nature
  • Join now to see all

Books/Book Chapters

  • Join now to see all

Abstracts/Posters

  • Glycosylation of Immunoglobulin Light Chains Is Highly Prevalent in Cold Agglutinin Disease
    Morie A. Gertz, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
  • Use of Maintenance Therapy Post Autologous Stem Cell Transplantation Outside of Clinical Trial Setting for Multiple Myeloma: Single Institution Experience
    Morie A Gertz, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
  • A Novel Approach to Risk Stratification in Multiple Myeloma Using ISS Stage and FISH
    Morie A Gertz, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
  • Join now to see all

Lectures

  • Adult Clinical Malignant Hematology 
    61st Annual American Society of Hematology Meeting - Orlando, FL - 12/7/2019
  • Results of the Phase 3 VITAL Study of NEOD001 (Birtamimab) Plus Standard of Care in Patients with Light Chain (AL) Amyloidosis Suggest Survival Benefit for Mayo Stage ... 
    61st Annual American Society of Hematology Meeting - Orlando, FL - 12/7/2019
  • Training Program DirectorsÍ Workshop 
    61st Annual American Society of Hematology Meeting - Orlando, FL - 12/7/2019
  • Join now to see all

Authored Content

  • Does Stem Cell Transplantation Provide Enough Benefit for Newly Diagnosed Multiple Myeloma Patients?June 2022
  • Systemic Amyloidosis Recognition, Prognosis, and TherapyJuly 2020
  • Systemic Amyloidosis Recognition, Prognosis, and TherapyJuly 2020

Press Mentions

  • Prothena to Present Data on Survival Benefit Observed in Completed Phase 3 Study of Drug Candidate Birtamimab in Patients with Mayo Stage IV AL Amyloidosis at the ASH 2022 Meeting
    Prothena to Present Data on Survival Benefit Observed in Completed Phase 3 Study of Drug Candidate Birtamimab in Patients with Mayo Stage IV AL Amyloidosis at the ASH 2022 MeetingNovember 3rd, 2022
  • Mayo Clinic Research in the News — 4/26/2021
    Mayo Clinic Research in the News — 4/26/2021April 26th, 2021
  • Design and Rationale of the Global Phase 3 NEURO-TTRansform Study of Antisense Oligonucleotide AKCEA-TTR-LRx (ION-682884-cs3) in Hereditary Transthyretin-Mediated Amyloid Polyneuropathy
    Design and Rationale of the Global Phase 3 NEURO-TTRansform Study of Antisense Oligonucleotide AKCEA-TTR-LRx (ION-682884-cs3) in Hereditary Transthyretin-Mediated Amyloid PolyneuropathyFebruary 26th, 2021
  • Join now to see all

Grant Support

  • Phase 3 Stem Cell Transplant For Light Chain AmyloidosisNational Cancer Institute2005–2011

Professional Memberships

Viewing the full profile is available to verified healthcare professionals only.

Find your profile and take control of your online presence: